177 related articles for article (PubMed ID: 36068200)
1. S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression.
Wang X; Qiu Z; Dong W; Yang Z; Wang J; Xu H; Sun T; Huang Z; Jin J
Cell Death Dis; 2022 Sep; 13(9):768. PubMed ID: 36068200
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
[TBL] [Abstract][Full Text] [Related]
4. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine-1-phosphate Receptor-1 Promotes Vascular Invasion and EMT in Hepatocellular Carcinoma.
Yokota T; Nojima H; Kuboki S; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Ohtsuka M
J Surg Res; 2021 Mar; 259():200-210. PubMed ID: 33307511
[TBL] [Abstract][Full Text] [Related]
6. SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.
Zhang H; Zheng Z; Zhang R; Yan Y; Peng Y; Ye H; Lin L; Xu J; Li W; Huang P
Cell Death Dis; 2021 Jul; 12(8):731. PubMed ID: 34301921
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling.
Balaji Ragunathrao VA; Anwar M; Akhter MZ; Chavez A; Mao Y; Natarajan V; Lakshmikanthan S; Chrzanowska-Wodnicka M; Dudek AZ; Claesson-Welsh L; Kitajewski JK; Wary KK; Malik AB; Mehta D
Cell Rep; 2019 Dec; 29(11):3472-3487.e4. PubMed ID: 31825830
[TBL] [Abstract][Full Text] [Related]
8. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma.
Zhang L; Xu J; Zhou S; Yao F; Zhang R; You W; Dai J; Yu K; Zhang Y; Baheti T; Pu L; Xu J; Qian X; Zhang C; Xia Y; Dai X; Li Q; Wang X
J Hepatol; 2024 Jan; 80(1):82-98. PubMed ID: 37838036
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
11. Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis.
Liu XT; Huang Y; Liu D; Jiang YC; Zhao M; Chung LH; Han XD; Zhao Y; Chen J; Coleman P; Ting KK; Tran C; Su Y; Dennis CV; Bhatnagar A; Liu K; Don AS; Vadas MA; Gorrell MD; Zhang S; Murray M; Kavurma MM; McCaughan GW; Gamble JR; Qi Y
J Transl Med; 2024 Jan; 22(1):43. PubMed ID: 38200582
[TBL] [Abstract][Full Text] [Related]
12. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
[TBL] [Abstract][Full Text] [Related]
13. Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth.
Sarkisyan G; Gay LJ; Nguyen N; Felding BH; Rosen H
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C14-24. PubMed ID: 24740542
[TBL] [Abstract][Full Text] [Related]
14. EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.
Gu F; Yuan S; Liu L; Zhu P; Yang Y; Pan Z; Zhou W
J Cell Mol Med; 2019 Jun; 23(6):4208-4216. PubMed ID: 30957411
[TBL] [Abstract][Full Text] [Related]
15. Endothelial sphingosine 1-phosphate receptors promote vascular normalization and antitumor therapy.
Cartier A; Leigh T; Liu CH; Hla T
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3157-3166. PubMed ID: 31988136
[TBL] [Abstract][Full Text] [Related]
16. Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma.
Li M; Zhang X; Wang M; Wang Y; Qian J; Xing X; Wang Z; You Y; Guo K; Chen J; Gao D; Zhao Y; Zhang L; Chen R; Cui J; Ren Z
Cancer Commun (Lond); 2022 Nov; 42(11):1162-1184. PubMed ID: 36181398
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals.
Dai W; Wang Y; Yang T; Wang J; Wu W; Gu J
Cell Commun Signal; 2019 Sep; 17(1):113. PubMed ID: 31477130
[TBL] [Abstract][Full Text] [Related]
18. Potential biomarkers Ang II/AT1R and S1P/S1PR1 predict the prognosis of hepatocellular carcinoma.
Ji Y; Chen H; Gow W; Ma L; Jin Y; Hui B; Yang Z; Wang Z
Oncol Lett; 2020 Nov; 20(5):208. PubMed ID: 32963614
[TBL] [Abstract][Full Text] [Related]
19. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-phosphate receptor 1 governs endothelial barrier function and angiogenesis by upregulating endoglin signaling.
Wang B; Dong N; Wu D; Fang Y; Chen J; Lin Y; Bellusci S; Zhang JS; Dai K; Chen C
Ann Transl Med; 2022 Feb; 10(3):136. PubMed ID: 35284541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
